Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
12.25
-0.08 (-0.65%)
At close: Dec 12, 2025, 4:00 PM EST
12.44
+0.19 (1.55%)
After-hours: Dec 12, 2025, 4:00 PM EST
Daxor Market Cap
Daxor has a market cap or net worth of $61.06 million as of December 12, 2025. Its market cap has increased by 36.68% in one year.
Market Cap
61.06M
Enterprise Value
61.32M
1-Year Change
36.68%
Ranking
Category
Stock Price
$12.25
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $61.06M, an increase of 101.74%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 61.46M | 65.12% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |